1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. IRIDEX CORP.
IRIDEX Corp.
XNAS: IRIX
0.89-0.01(-1.11%)
188.9K

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

IRIDEX Corp quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for IRIDEX Corp share price target, revenues, EPS, net income and more

IRIDEX Corp quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEGATIVE

    Quarterly Revenue IRIDEX Corp Jun-2026 Quarterly Revenue is $13 Million which is growth of -7.4% YoY.

  • NEGATIVE

    Quarterly Net Profit IRIDEX Corp Jun-2026 Quarterly Net Profit is $-1 Million which is growth of -27.4% YoY.

IRIDEX Corp., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
12.611.814.712.513.611.912.711.612.611.812.512.912.9
Cost Of Rev.
8.37.19.38.58.96.87.17.37.57.37.67.27.5
Gross Profit
4.34.75.544.75.15.64.35.14.54.95.65.4
⌄
5.35.15.55.45.65.36.16.27.87.887.38.3
Operating Profit
-1-0.3-0-1.4-0.9-0.2-0.5-1.9-2.6-3.3-3.1-1.7-2.9
-------------
Profit Before Tax
-1.2-0.5-0.2-1.6-1-1.7-0.8-1.9-2.7-3.4-2.9-1.8-2.8
Tax
0.10.1000-00000.100
⌄
-1.3-0.5-0.2-1.6-1-1.7-0.8-1.9-2.7-3.5-3-1.8-2.8
Diluted NI Avail to Com Stockholders Ann.
-1.3-0.5-0.2-1.6-1-1.7-0.8-1.9-2.7-3.5-3-1.8-2.8
Basic EPS
-0.1-0-0-0.1-0.1-0.1-0.1-0.1-0.2-0.2-0.2-0.1-0.2
Diluted EPS After ExtraOrdinary
-0.1-0-0-0.1-0.1-0.1-0.1-0.1-0.2-0.2-0.2-0.1-0.2
Number Of Shares End
17.417.317.21716.816.716.616.616.316.316.216.216
Net Income Continuing Discontinued Operations
-1.3-0.5-0.2-1.6-1-1.7-0.8-1.9-2.7-3.5-3-1.8-2.8
Normalized Income
-1.1-0.4-0-1.5-0.8-0.5-0.5-1.8-2.4-3.2-2.6-1.5-2.5
Interest Income
-------------
Interest
-------------
Net Interest Income
-------------
EBIT
-1.2-0.5-0.2-1.6-1-1.7-0.8-1.9-2.7-3.4-2.9-1.8-2.8
EBITDA
-0.8-0.10.3-1.2-0.6-1.3-0.5-1.6-2.3-3-2.1-1.4-2.2
Reconciled Cost Of Rev.
8.37.19.38.58.96.87.17.37.57.37.67.27.5
Reconciled Depr.
0.40.40.40.40.40.40.40.30.40.40.80.40.5
Profit From Continuing Operations
-1.3-0.5-0.2-1.6-1-1.7-0.8-1.9-2.7-3.5-3-1.8-2.8
Normalized EBITDA
-0.70.10.4-1-0.60.2-0.1-1.6-2.3-2.9-2.3-1.3-2.4
*All financials are in USD Million and price data in USD

IRIDEX Corp competitor comparison and performance snapshot within industry

IRIDEX Corp annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue IRIDEX Corp Dec-2025 Annual Revenue is $53 Million which is growth of 8.2% YoY.

  • POSITIVE

    Annual Net Profit IRIDEX Corp Dec-2025 Annual Net Profit is $-4 Million which is growth of 50.2% YoY.

IRIDEX Corp., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-2.6%
7.7%
 52.748.751.95753.936.443.542.641.646.241.8
Cost Of Rev. Ann.
2%
10%
3333.529.230.131.631.120.825.525.126.125.321.8
Gross Profit Ann.
-8.9%
4.2%
18.519.219.521.825.422.815.617.917.515.520.820
Operating Exp. Ann.
-12.8%
-0.3%
21.321.827.831.832.930.422.126.930.328.523.319.7
Operating Profit Ann.
-
-
-2.8-2.6-8.3-10-7.5-7.5-6.6-9-12.9-13-2.40.3
-
-
 -----------
Other Exp. Ann.
-
-
 -1.8-0.50.50.12.40.30.20.10-0.2
PBT Ann.
-
-
-3.4-4.4-8.8-9.5-7.5-5.2-6.3-8.8-12.8-13-2.70.3
Tax Ann.
0%
-
0.20.10.10.10.1000.10-0.19.1-0.2
⌄
-
-
-3.5-4.4-8.9-9.6-7.6-5.2-6.3-8.8-12.8-12.9-11.70.5
Diluted NI Avail to Com Stockholders Ann.
-
-
-3.5-4.4-8.9-9.6-7.6-5.2-6.3-8.8-12.8-12.9-11.70.5
EPS Ann.
-
-
 -0.3-0.5-0.6-0.5-0.3-0.5-0.6-1.1-1.1-1.20.1
Diluted EPS Ann.
-
-
 -0.3-0.5-0.6-0.5-0.3-0.5-0.6-1.1-1.1-1.20.1
Number Of Shares End
2.4%
4.4%
 17.216.616.21615.913.913.813.611.610.410
Total Exp. Ann.
-5%
5.2%
 55.35761.964.561.442.952.455.554.648.641.5
Net Income Continuing Discontinued Operations Ann.
-
-
-3.5-4.4-8.9-9.6-7.6-5.2-6.3-8.8-12.8-12.9-11.70.5
Normalized Income Ann.
-
-
-3-2.1-7.9-8.3-6.3-5.9-5.5-7.6-11.5-11.1-10.61
Interest Income Ann.
-
-
 -----------
Interest Ann.
-
-
 -----------
EBITDA Ann.
-
-
-1.9-2.8-7.4-7.5-6.1-4.4-5.8-8.1-12-12.1-20.8
Reconciled Cost Of Rev. Ann.
2%
10%
3333.529.230.131.631.120.825.525.126.125.321.8
Reconciled Depr. Ann.
4.6%
26.2%
1.51.61.421.40.80.50.70.80.90.70.5
Profit From Continuing Operations Ann.
-
-
-3.5-4.4-8.9-9.6-7.6-5.2-6.3-8.8-12.8-12.9-11.70.5
Normalized EBITDA Ann.
-
-
-1.3-1-6.9-8-6.2-6.7-6.1-8.3-12.1-12.3-1.70.8
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
8.2%
2Y CAGR
0.8%
3Y CAGR
-2.6%
5Y CAGR
7.7%
7Y CAGR
3.1%
10Y CAGR
2.3%
Total Revenue Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
-21.6%
2Y CAGR
-17.2%
3Y CAGR
-12.8%
5Y CAGR
-0.3%
7Y CAGR
-4.6%
10Y CAGR
1%
Operating Expenses Annual Cr is falling faster than historical averages.

IRIDEX Corp balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund IRIDEX Corp Dec-2025 Total Shareholders Fund is $-1 Million which is growth of -151.4% YoY.

  • POSITIVE

    Total Assets IRIDEX Corp Dec-2025 Total Assets is $29 Million which is growth of 0.1% YoY.

IRIDEX Corp., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-11.6%
0.8%
29.229.134.442.348.72834.841.741.748.141.8
⌄
-1.2%
18%
24.22724.925.125.410.612.111.711.198.1
⌄
-
-
-1.12.19.517.223.317.422.73030.539.233.7
Total Capitalization Ann.
-20.3%
-14.1%
8.73.19.517.223.318.622.73030.539.233.7
Tangible Assets Ann.
-40.6%
-29.1%
3-0.26.914.320.116.822.129.329.938.532.9
Working Capital Ann.
-19.8%
-6.4%
12714.523.329.616.720.828.529.137.423.3
Invested Capital Ann.
-46.1%
-32.9%
2.74.89.517.223.319.922.73030.539.233.7
Tangible Book Value Ann.
-
-
-3-0.26.914.320.116.822.129.329.938.532.9
Borrowings Ann.
35.7%
1.4%
4.54.62.81.82.74.23.2----
Net Debt Ann.
-
-
-0.4---------
Share Issued Ann.
2.6%
4.5%
17.316.616.31615.913.913.813.611.611.310
Number Of Shares End
2.4%
4.4%
17.216.616.21615.913.913.813.611.610.410
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
0.3%
2Y CAGR
-7.9%
3Y CAGR
-11.6%
5Y CAGR
0.8%
7Y CAGR
-5%
10Y CAGR
-3.5%
Total Assets Annual growth is stable compared to historical averages.
Total Current Liabilities Ann.
1Y CHG
-20.5%
2Y CAGR
0.8%
3Y CAGR
1.8%
5Y CAGR
8.7%
7Y CAGR
2.5%
10Y CAGR
6%
Total Current Liabilities Annual Cr is falling faster than historical averages.

IRIDEX Corp ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share IRIDEX Corp Book Value Per Share is $-0 which is growth of -148.3% YoY.

  • NEUTRAL

    ROE IRIDEX Corp ROE is 0% which is growth of 0% YoY.

IRIDEX Corp., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--28.03%-24.95%-16.59%-13.63%-20.16%-23.04%-30.76%-28.66%-26.04%1.13%
ROE Ann. %
-
-
--153.37%-71.54%-37.24%-25.70%-31.59%-33.47%-42.37%-36.93%-32.16%1.41%
ROIC %
-
-
--11.7-21.7-5.9-9-0.8-5.8-9.1-15.7-29.31.3
OPM Ann. %
-
-
-4.88%-17.06%-19.29%-13.24%-13.98%-18.11%-20.66%-30.21%-31.32%-5.30%0.69%
Inventory Turnover Ratio Ann.
-
-
-2.82.93.54.7332.82.52.22.2
Asset Turnover Ann. %
-
-
-1.51.41.31.41.21.110.911
Working Capital Turnover Ann.
22.4%
14.9%
4.473.62.41.82.22.11.51.41.21.8
Quick Ratio Ann.
-
-
-0.71.31.92.72.22.32.72.942.6
Current Ratio Ann.
-
-
-1.42.12.93.32.93.13.63.85.44.1
Interest Coverage Ratio Ann.
-
-
-----------
LT Debt To Equity Ann.
-
-
-0.90.200.10.10.1----
*All financials are in USD Million and price data in USD

IRIDEX Corp cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity IRIDEX Corp Dec-2025 Cash From Operating Activity is $-2 Million which is growth of 71.0% YoY.

  • POSITIVE

    Net Cash Flow IRIDEX Corp Dec-2025 Net Cash Flow is $4 Million which is growth of 179.0% YoY.

IRIDEX Corp., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
-2.1-7.3-6.7-9.58.2-3.2-7.9-10-3.6-0.1-0.6
-
-
-0.1-0-0.1-0.3-5.6-0.1-0.5-0.8-0.8-1.5-1.3
-
19.1%
62.6-0.19.52.5-0.210.42.315.4-1.4
Cash Plus Cash Eqv. End Of Year Ann.
-24.4%
-12.4%
62.4713.923.911.612.721.221.723.810
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
3.7-4.7-6.9-9.912.1-0.9-8.6-0.5-213.8-3.3
Cash Plus Cash Eqv. Begin Of Year Ann.
-53.5%
-28.3%
2.4713.923.911.612.721.221.723.81013.3
Income Tax Paid Supplemental Data Ann.
-
-
-00.10.10-00000
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
-0.1-0-0.1-0.3-0.2-0.1-0.1-0.4-0.6-1.1-0.9
Issuance Of Capital Stock Ann.
-
-
103.4-9.9-10.52.314.8-
Issuance Of Debt Ann.
-
-
----2.5-----
Repayment Of Debt Ann.
-
-
-4-0.2---------
Repurchase Of Capital Stock Ann.
-
-
----------0.1-1.6
Free Cash Flow Ann.
-
-
-2.3-7.3-6.9-9.88-3.3-8-10.5-4.1-1.2-1.5
*All financials are in USD Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
130.8%
5Y CAGR
19.1%
7Y CAGR
-7.6%
Cash from Financing Annual Activity growth is stable compared to historical averages.